Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositoI cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes

Acta Diabetologica

Volumn 33, Issue 2, 1996, Pages 126-138

  Wasner, H K ^a   Lessmann M ^a   Conrad, M ^a   Amini, H ^a   Psarakis, E ^a   Mir Mohammad Sadegh, A ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

Author keywords

Activated inositol polyphosphate; Insulin action; Noradrenaline; Prostaglandin E; Prostaglandylinositol cyclic phosphate

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; CYCLIC AMP; FLUORIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; INOSITOL PHOSPHATE; INOSITOL POLYPHOSPHATE; NORADRENALIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PROSTAGLANDIN A; PROSTAGLANDIN E; PROSTAGLANDYLINOSITOL CYCLIC PHOSPHATE; PYROPHOSPHATE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ALPHA ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME KINETICS; ENZYME SPECIFICITY; ISOMER; LIVER CELL MEMBRANE; NONHUMAN; PH; PRIORITY JOURNAL; RAT;

EID: 0029739566     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00569423     Document Type: Article

References (77)

1. Wasner HK, Leßmann M, Weber S, Prostaglandylinositol cyclic phosphate (cPIP), a second messenger for insulin (abstract 8). Diabetes 39 [Suppl 1]:2a, 1990
2. Wasner HK, Prostaglandylinositol cyclic phosphate (cPIP), a second messenger for insulin (abstract 49). Acta Endocrinol 122 [Suppl 1] 25, 1990
3. Leßmann M, Wasner HK, Zur Biosynthese des cAMP-Antago-nisten cPIP in der Leber-Plasmamembran der Ratte (abstract). Akt Endokrinol Stoffwechsel 11:71, 1990
4. Conrad M, Mir-Mohammad-Sadegh A, Wasner HK, Die Bio-synthese von Prostaglandylinositol-zyklophosphat (cPIP) in der Plasmamembran der Rattenleber (abstract). Diabetes Stoffwechsel 2:118, 1993
5. Wasner HK, Conrad M, Amini-Hadi-Kiashar H, Mirmoham-mad-Sadegh A, On the biosynthesis of the endogenous cyclic AMP antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP) (abstract). Biol Chem Hoppe Seyler 374:733, 1993
6. Wasner HK, Conrad M, Amini H, Kaiser A, Gypakis A, Thome C, Inositolpolyphosphates in the biosynthesis of the cyclic AMP antagonist cyclic PIP (abstract). Exp Clin Endocrinol 102:A5, 1994
7. Psarakis E, Wasner HK, The synthesis of the endogenous c AMP antagonist cPIP is significantly reduced in liver plasma membranes of SHR-rats and Ksj db/db mice (abstract). Exp Clin Endocrinol 103:A23, 1995
8. Murad F, Rall TW, Vaughan M, Conditions for the formation, partial purification and assay of an inhibitor of adenosine 3′,5′-monophosphate. Biochim Biophys Acta 192:430-445, 1969
9. Ho RJ, Sutherland EW, Formation and release of a hormone antagonist by rat adipocytes. J Biol Chem 246:6822-6827, 1971
10. Ho RJ, Bomboy JD, Wasner HK, Sutherland EW, Preparation and characterization of a hormone antagonist from adipocytes. Methods Enzymol 37:431-438, 1975
11. Ho RJ, Sutherland EW, cAMP-mediated feedback regulation in target cells. Adv Cyclic Nucleotide Res 5:533-548, 1975
12. Cheng K, Larner J, Intracellular mediators of insulin action. Annu Rev Physiol 47:405-424, 1985
13. Lamer J, Cheng K, Schwartz C, Dubler R, Creacy S, Kikuchi K, Tamura S, Galasko G, Pullin C, Katz M, Chemical mechanism of insulin action via proteolytic formation of mediator peptides. Mol Cell Biochem 40:155-161, 1981
14. Kiechle FL, Jarett L, Kotagal N, Popp DA, Partial purification from rat adipocyte plasma membranes of a chemical mediator which simulates the action of insulin on pyruvate dehydrogenase. J Biol Chem 256:2945-2951, 1981
15. Seals J, Czech MP, Evidence that insulin activates an intrinsic plasma membrane protease in generating a secondary chemical mediator. J Biol Chem 255:6529-6531, 1980
16. Saltiel AR, Fox JA, Sherline P, Cuatrecasas P, Insulin-stimulated hydrolysis of a novel glycohpid generates modulaters of cAMP phosphodiesterase. Science 233:967-972, 1986
17. Saltiel AR, Cuatrecasas P, In search of a second messenger for insulin. Am J Physiol 255 (Cell Physiol 24):C1-C11, 1988
18. Mato JM, Kelly KL, Abler A, Jarett L, Identification of a novel insulin-sensitive glycophospholipid from H35 hepatoma cells. J Biol Chem 262:2131-2137, 1987
19. Alvarez JF, Varely I, Ruiz-Albusac JM, Mato JM, Localisation of the insulin-sensitive phosphatidylinositol glycan at the outer surface of the cell membrane. Biochem Biophys Res Commun 152:1455-1462, 1988
20. Asplin I, Galasko G, Larner J, Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemo-dialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci USA 90:5924-5928, 1993
21. Wasner HK, Regulation of protein kinase and phosphoprotein phosphatase by cyclic AMP and cyclic AMP antagonist. FEES Lett 57:60-63, 1975
22. Wasner HK, Biosynthesis of cyclic AMP antagonist in hepatocytes from rats after adrenalin- or insulin-stimulation (isolation, purification and prostaglandin E requirement for its synthesis). FEBS Lett 133:260-264, 1981
23. Wasner HK, Prostaglandylinositol cyclic phosphate (an antagonist to cyclic AMP). In: Bailey JM (ed) Prostaglandins, leukotrienes and lipoxins. Plenum, New York, pp 251-257, 1985
24. Partke HJ, Wasner HK, Cyclic AMP antagonist, a second messenger for insulin action, inhibits glucose-stimulated insulin secretion in isolated islets of Chinese hamsters. In: Atwater I, Rojas E, Soria D (eds) Biophysics of the pancreatic β-cell. Plenum, New York, pp 409-412, 1987
25. Wasner HK, Salge U, Prostaglandylinositol cyclic phosphate, an antagonist to cyclic AMP. Adv Prostaglandin Thromboxane Leukotriene Res 17:691-695, 1987
26. Wasner HK, Lemoine H, Junger E, Leßmann M, Kaufmann R, Prostaglandylinositol cyclic phosphate, a new second messenger. In: Bailey JM (ed) Prostaglandins, leukotrienes, lipoxins and PAF. Plenum, New York, pp 153-168, 1991
27. Wasner HK, Kaufmann R, Lemoine H, Mass spectrometric identification of prostaglandylinositol, the dephosphorylated cyclic AMP antagonist, cyclic PIP. Analusis 20:171-177, 1992
28. Wasner HK, Salge U, Gebel M, The endogenous cyclic AMP antagonist, cyclic PIP: its ubiquity, hormone stimulated synthe sis and identification as prostaglandylinositol cyclic phosphate. Acta Diabetol 30:220-232, 1993
29. Wasner HK, Weber S, Partke HJ, Amini-Hadi-Kiashar H, Indomethacin treatment causes loss of insulin action in rats: involvement of prostaglandins in the mechanism of insulin action. Acta Diabetol 31:175-182, 1994
30. White MF, Kahn CR, The insulin signaling system. J Biol Chem 269:1-4, 1994
31. Denton RM, Tavaré JM, Does mitogen-activated-protein kinase have a role in insulin action? The cases for and against. Eur J Biochem 227:597-611, 1995
32. 2+, 5′AMP and ADP on cyclic AMP-induced activation of phosphorylase in liver extract preparations (abstract). Adv Cyclic Nucleotide Res 9:774, 1978
33. Shaw JE, Ramwell PW, Separation, identification and estimation of prostaglandins. Methods Biochem Anal 17:325-371, 1969
34. Saltiel AR, Insulin generates an enzyme modulator from hepatic plasma membranes: regulation of adenosine 3′,5′-monophosphate phosphodiesterase. pyruvate dehydrogenase. and adenylate cyclase Endocrinology 120:967-972, 1987
35. Kelly KL, Mato JM, Merida I, Jarett L, Glucose transport and antilipolysis are differentially regulated by the polar head group of an insulin-sensitive glycophospholipid. Proc Natl Acad Sci USA 84:6404-6407, 1987
36. Thakker JK, DiMarchi R, MacDonald K, Caro JF, Effect of insulin and insulin-like growth factors I and II on phosphatidylinositol and phosphatidylinositol 4,5-bisphosphate breakdown in liver from humans with and without type II diabetes. J Biol Chem 264:7169-7175, 1989
37. Denton RM, Midgley PJN, Rutter GA, Thomas AP, McCormack JG, Studies into the mechanism whereby insulin activates pyruvate dehydrogenase complex in adipose tissue. Ann NY Acad Sci 573:285-296, 1989
38. Kellerer M, Machicao F, Bert L, Sixt B, Mushack J, Seffer E, Mosthaf L, Ullrich A, Häring HU, Inositol phospho-oligosac-charides from rat fibroblasts and adipocytes stimulate 3-O methylglucose transport. Biochem J 295:600-704, 1993
39. Wasner HK, Preparation of a liver plasma membrane with an adrenaline-responsive adenylyl cyclase after inhibition of prostaglandin synthesis by indomethacin. FEES Lett 72:127-130, 1976
40. Smith PH, Kron RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC, Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85, 1985
41. Baginski ES, Foa PP, Zak B, Glucose-6-phosphatase. In: Bergmeier HU (ed) Methoden der enzymatischen Analyse, 3rd edn. Vol 1. Verlag Chemie. Weinheim, pp 909-913, 1974
42. Fiske CH, Subbarow Y, The colorimetric determination of phosphorus. J Biol Chem 66:375, 1925
43. Morre JD, Isolation of golgi apparatus. Methods Enzymol 22: 130-148, 1971
44. Salomon Y, Londos C, Rodbell M, A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548, 1974
45. Guthrie RD, Periodate oxidation. In: Whistler RL, Wolfrom ML, BeMiller JN, Shafizadeh F (eds) Methods in carbohydrate chemistry. Vol 1. Academic Press, New York, pp432-435, 1962
46. Gumber SC, Lowenstein JM, Non-enzymic phosphorylation of polyphosphoinositides and phosphatidic acid is catalysed by bivalent metal ions. Biochem J 235:617-619, 1986
47. 3H]-inositol into inositol polyphosphates during development of dictyostelium. Biochem Biophys Res Commun 181:191-196, 1991
48. Mayr GW, Radenberg T, Thiel U, Vogel G, Stephens LR, Phosphomositol diphosphates: non-enzymic formation in vitro and occurrence in vivo in the cellular slime mold Dictyostelium. Carbohydrate Res 234:247-262, 1992
49. Fox J, Soliz NM, Saltiel AR, Purification of a phosphatidylinositol-glycan-specific phospholipase C from liver plasma membranes: a possible target of insulin action. Proc Natl Acad Sci USA 84:2663-2667, 1987
50. Salge U, Untersuchungen zur biologischen Synthese des cAMP-Antagonisten. Thesis, Heinrich-Heine-Universitat. Düsseldorf, 1987
51. Leßmann M, Zur 'in vitro' Biosynthese des cAMP-Antagonisten Prostaglandylinositol-cyclophosphat (cPIP). Thesis, Hein-rich-Heine-Universität, Düsseldorf, 1991
52. Wasner HK, Amini A, Gypakis A, Psarakis E, Biosynthesis and action of the endogenous cAMP antagonist cPIP (abstract). 9th International Conference on Second Messengers & Phosphoproteins, Nashville, USA. October 1995
53. Amini H, Wasner HK, The mediator of insulin action, cyclic PIP is biosynthesized from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes: regulatory mechanisms controlling the activity of cyclic PIP synthetase (abstract). Exp Clin Endocrinol (in press), 1996
54. Sternweis PC, Northup JK, Hanski E, Schleifer LS, Smigel MD, Gilman AG, Purification and properties of the regulatory component (G/F) of adenylate cyclase. Adv Cyclic Nucleotide Res 14-23-36, 1981
55. Gypakis A, Amini-Hadi-Kiashar H, Wasner HK, The endogenous cAMP antagonist cPIP is biosynthesized from prostaglandin E and guanosine diphosphate inositol phosphate (abstract). Exp Clin Endocrinol 103:A16, 1995
56. Casey PJ, Moomaw JF, Zhang FL, Higgins JD, Thissen JA, Prenylation and G protein signaling. Recent Prog Horm Res 49:215-238, 1994
57. Butcher RW, Baird CE, Effects of prostaglandins on adenosine 3′,5′-monophosphate levels in fat and other tissues. J Biol Chem 243:1713-1717, 1968
58. Wlodawer P, Samuelsson B, On the organization and mechanism of protaglandin synthetase. J Biol Chem 248:5673-5678, 1973
59. 2 and arachidonic acid release in signal transduction. Biochem Soc Trans 18:503-507, 1990
60. 1-adrenergic stimulation in FRTL5 thyroid cells. Proc Natl Acad Sci USA 83:7201-7205, 1986
61. Kanterman RY, Axelrod J, Felder CC, Alpha-1 adrenergic receptor mediates the release of arachidonic acid in spinal cord neurons independent of phosphatidylinositol-specific phospholipase C. Adv Second Messenger Phosphoprotein Res 24: 158-163, 1990
62. Park D, Jhon DY, Lee CW, Lee KH, Rhee SG, Activation of phospholipase C isozymes by G protein βγ subunits. J Biol Chem 268:4573-4576, 1993
63. Koepfer-Hobelsberger B, Wieland OH, Insulin activates phospholipase C in fat cells' similarity with the activation of pyruvate dehydrogenase. Mol Cell Endocrinol 36:123-129, 1984
64. Rhee SG, Choi KD, Regulation of inositol phospholipid-specific phospholipase C isozymes. J Biol Chem 267:12393-12396, 1992
65. Farese RV, Kuo JY, Babischkin JS, Davis JS, Insulin provokes a transient activation of phospholipase C in the rat epididymal fat pad. J Biol Chem 261:8589-8592, 1986
66. 2 block the stimulation of protein synthesis by insulin in L6 myoblasts. Biochem J 270:737-739, 1990
67. αi3 regulate multiple effector enzymes in the same cell. J Biol Chem 269:29565-29570, 1994
68. 1, by tyrosine phosphorylation. Science 250:1253-1256, 1990
69. Park DJ, Min HK, Rhee SG, Inhibition of CD3-linked phospholipase C by phorbol ester and by cAMP is associated with decreased phosphotyrosine and increased phosphoserine contents of PLC-gammal. J Biol Chem 267:1496-1501, 1992
70. 2 activation: potentiation by vanadate. Biochem J 295:879-888, 1993
71. 2 pathway by FceR1 is not shared by a G protein-coupled receptor. J Biol Chem 270:10960-10967, 1995
72. Rothenberg PL, Lane WS, Karasik A, Backer J, White M, Kahn CR, Purification and partial sequence analysis of pp 185, the major cellular substrate of the insulin receptor tyrosine kinase. J Biol Chem 266:8302-8311, 1991
73. Goren HJ, Boland D, The 180 000 molecular weight plasma membrane insulin receptor substrate is a protein tyrosine phosphatase and is elevated in diabetic plasma membranes. Biochem Biophys Res Commun 180:463-469, 1991
74. Brass EP, Garrity MJ, Structural specificity for prostaglandin effects on hepatocyte glycogenolysis. Biochem J 267:59-62, 1990
75. 2+ mobilizing receptor agonists or phorbol ester. J Biol Chem 264:15186-15191, 1989
76. 1 and to phosphoinositide metabolism in a pertussis toxin-insensitive manner. J Biol Chem 264:3916-3923, 1989
77. Majerus PW, Inositol phosphate biochemistry. Annu Rev Biochem 61:235-250, 1992